Covaxin To Use ViroVax’s Adjuvant To Boost Immunity
New Delhi: Covaxin, India's first indigenous COVID vaccine, will use adjuvant Alhydroxiquim-II to increase immune response, informed Bharat Biotech on Monday.
ViroVax LLC, a Kansas based company, has licensed their adjuvant for the use of…